The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma.
Osama ElbazRana M ShaatHasan A Abd El GhaffarSameh ShamaaHanaa M Abdel-MasseihNahla AnberMetwaly Ibrahim MortadaPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
MYD88 L265P and to lesser extent TNFAIP3 mutations are major mutations in ABC- DLBCL and may be predictive factors for poor OS in ABC- DLBCL patients.